Screener
Fulgent Genetics, Inc. FLGT Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current assets | ||
| Cash and cash equivalents | $23,399 | $50,193 |
| Marketable securities | 252,903 | 285,884 |
| Trade accounts receivable, net of allowance for credit losses of $21,420 as of March 31, 2026, and $21,411 as of December 31, 2025 | 69,277 | 84,762 |
| Prepaid income taxes | 109,165 | 107,099 |
| Other current assets | 24,298 | 22,552 |
| Total current assets | 479,042 | 550,490 |
| Marketable securities, long-term | 328,287 | 369,269 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s accounts receivable?
- Fulgent Genetics, Inc. (FLGT) reported accounts receivable of $69.28M in Q1 2026.
- How has Fulgent Genetics, Inc.'s accounts receivable changed year-over-year?
- Fulgent Genetics, Inc.'s accounts receivable decreased by 3.1% year-over-year, from $71.48M to $69.28M.
- What is the long-term trend for Fulgent Genetics, Inc.'s accounts receivable?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s accounts receivable has grown at a -14.3% compound annual growth rate (CAGR), from $183.86M to $84.76M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about Fulgent Genetics, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude